Annals of Business Administrative Science (May 2016)

Drug Discovery Process

  • Kenichi KUWASHIMA

DOI
https://doi.org/10.7880/abas.0160224a
Journal volume & issue
Vol. 15, no. 3
pp. 129 – 138

Abstract

Read online

In pharmaceutical research and development of drugs, discovering new drugs from a large number of potential alternatives (chemical compounds), which are theoretically as many as 1060, is an important challenge. Here the new-drug discovery process was explored through a case study on Rozerem from Takeda Pharmaceutical Company Limited. Although the recent mainstream approach is to generate and test a large number of alternatives using automation technologies, Rozerem was discovered through exploration of a small number of alternatives with rational chemical compound design, based on researchers’ experience and knowledge.

Keywords